Skip to main content
Powered by ShareScore

Find research datasets worth reusing

Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.

5,225

datasets available to search

ShareScore release 0.9.0

Reset

Dataset results

5,225 results for “moderation”

Learn how ShareScore rates datasets ↗
ClinicalTrials.gov28/100

Buprenorphine Sublingual Spray for the Treatment of Moderate to Severe Pain

ClinicalTrials.gov study NCT02310581. IPD Sharing: Not stated. Countries: 1. Publications: 0.

restrictedIPD-UNDECIDEDFeb 2026View details →
ClinicalTrials.gov28/100

Study Evaluating of Recombinant Human Factor IX (BeneFIX) and a New Formulation of BeneFIX (rFIX-R) in Moderate to Severe Hemophilia B

ClinicalTrials.gov study NCT00093210. IPD Sharing: Not stated. Countries: 0. Publications: 2.

restrictedIPD-UNDECIDEDFeb 2026View details →
ClinicalTrials.gov28/100

Efficacy and Safety of REGN3500 Monotherapy and Combination of REGN3500 Plus Dupilumab in Adult Patients With Moderate-to-Severe Atopic Dermatitis

ClinicalTrials.gov study NCT03736967. IPD Sharing: Not stated. Countries: 7. Publications: 0.

restrictedIPD-UNDECIDEDFeb 2026View details →
ClinicalTrials.gov28/100

A Study of Aticaprant 10 Milligrams (mg) as Adjunctive Therapy in Adult Participants With MDD With Moderate-to-severe Anhedonia and Inadequate Response to Current Antidepressant Therapy

ClinicalTrials.gov study NCT05550532. IPD Sharing: YES. Countries: 14. Publications: 0.

controlledIPD-YESFeb 2026View details →
ClinicalTrials.gov28/100

Pain and Safety of Restylane Perlane With and Without Lidocaine for Correction of Moderate and Severe Nasolabial Folds

ClinicalTrials.gov study NCT03174132. IPD Sharing: NO. Countries: 1. Publications: 0.

closedIPD-NOFeb 2026View details →
ClinicalTrials.gov28/100

A Study Comparing Different Dosing Regimens of Ixekizumab (LY2439821) in Participants With Moderate to Severe Plaque Psoriasis

ClinicalTrials.gov study NCT02513550. IPD Sharing: YES. Countries: 14. Publications: 0.

controlledIPD-YESFeb 2026View details →
ClinicalTrials.gov28/100

Pharmacokinetics, Pharmacodynamics, and Safety of Single-dose Sotrovimab in High-risk Pediatric Participants With Mild to Moderate COVID-19

ClinicalTrials.gov study NCT05124210. IPD Sharing: YES. Countries: 1. Publications: 0.

controlledIPD-YESFeb 2026View details →
ClinicalTrials.gov28/100

A Study of Mirikizumab (LY3074828) in Participants With Moderate to Severe Plaque Psoriasis

ClinicalTrials.gov study NCT02899988. IPD Sharing: YES. Countries: 6. Publications: 0.

controlledIPD-YESFeb 2026View details →
ClinicalTrials.gov28/100

Phase 2 Study of SAR444656 in Adult Participants With Moderate to Severe Atopic Dermatitis

ClinicalTrials.gov study NCT06058156. IPD Sharing: YES. Countries: 6. Publications: 0.

controlledIPD-YESFeb 2026View details →
ClinicalTrials.gov28/100

Effect of Glycopyrronium on Morning Symptoms and Pulmonary Function in Patients With Moderate to Severe COPD

ClinicalTrials.gov study NCT01959516. IPD Sharing: Not stated. Countries: 4. Publications: 0.

restrictedIPD-UNDECIDEDFeb 2026View details →
ClinicalTrials.gov28/100

Patient Satisfaction Following Twice Daily Dosing With DFD-01 in Subjects With Moderate Plaque Psoriasis

ClinicalTrials.gov study NCT02749799. IPD Sharing: NO. Countries: 1. Publications: 0.

closedIPD-NOFeb 2026View details →
ClinicalTrials.gov28/100

Treatment of Mild to Moderate Depression Symptoms in Patients With Spinal Cord Injury

ClinicalTrials.gov study NCT00735670. IPD Sharing: Not stated. Countries: 1. Publications: 0.

restrictedIPD-UNDECIDEDFeb 2026View details →
ClinicalTrials.gov28/100

A Dose-ranging Study to Investigate Efficacy of Buntanetap in Mild to Moderate AD

ClinicalTrials.gov study NCT05686044. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.

restrictedIPD-UNDECIDEDFeb 2026View details →
ClinicalTrials.gov28/100

A Study to Evaluate the Anti-pruritic Effectiveness of ASN008 in Adults With Mild to Moderate Atopic Dermatitis

ClinicalTrials.gov study NCT05870865. IPD Sharing: NO. Countries: 1. Publications: 0.

closedIPD-NOFeb 2026View details →
ClinicalTrials.gov28/100

A Study to Assess the Pharmacokinetics, Safety, and Efficacy of Two Doses of Bimekizumab in Adolescent Study Participants With Moderate to Severe Plaque Psoriasis

ClinicalTrials.gov study NCT04718896. IPD Sharing: YES. Countries: 4. Publications: 0.

controlledIPD-YESFeb 2026View details →
ClinicalTrials.gov28/100

BGS649 Monotherapy in Moderate to Severe Endometriosis Patients

ClinicalTrials.gov study NCT01190475. IPD Sharing: NO. Countries: 1. Publications: 0.

closedIPD-NOFeb 2026View details →
ClinicalTrials.gov28/100

A Study of Guselkumab in Participants With Moderately to Severely Active Crohn's Disease

ClinicalTrials.gov study NCT04397263. IPD Sharing: YES. Countries: 1. Publications: 0.

controlledIPD-YESFeb 2026View details →
ClinicalTrials.gov28/100

A Study to Learn About The Study Medicine (PF-07038124) In Patients With Mild To Moderate Atopic Dermatitis Or Mild To Severe Plaque Psoriasis.

ClinicalTrials.gov study NCT05375955. IPD Sharing: YES. Countries: 4. Publications: 0.

controlledIPD-YESFeb 2026View details →
ClinicalTrials.gov28/100

Human Anti-TNF Monoclonal Antibody Adalimumab in Canadian Subjects With Moderate to Severe Crohn's Disease (ACCESS)

ClinicalTrials.gov study NCT00427921. IPD Sharing: Not stated. Countries: 1. Publications: 0.

restrictedIPD-UNDECIDEDFeb 2026View details →
ClinicalTrials.gov28/100

Follow-up of Rheumatoid Arthritis (RA) Moderate to Low Disease Activity Study

ClinicalTrials.gov study NCT00843778. IPD Sharing: Not stated. Countries: 5. Publications: 0.

restrictedIPD-UNDECIDEDFeb 2026View details →

ScienceDex guides

Understand access before you commit

These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.

Compare curated datasets

Allen Brain Atlas

Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.

allen-brain-atlas
neuroscienceopenDocumentation, web resources, and API references are available online.
Last verified 2026-04-30Open record

Annotated Behaviour and Observability Dataset (ABODe)

ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.

abode-home-cage
behavioral-neuroscienceopenThe DataShare record exposes download links for annotations, documentation, license text, and the zipped per-snippet data directory.
Last verified 2026-04-30Open record

DANDI Archive for NWB datasets

DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.

dandi-nwb
electrophysiologyopenPublished Dandiset metadata and archive endpoints are available through the production DANDI API.
Last verified 2026-04-30Open record

International Brain Laboratory public data

The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.

ibl
behavioral-neuroscienceopenPublic sessions can be searched and loaded from the IBL public data server through ONE.
Last verified 2026-04-29Open record

OpenNeuro

OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.

openneuro
neuroscienceopenPublished datasets are available on demand over the internet.
Last verified 2026-04-29Open record

ScienceDex for faculty

Your academic CV and NIH biosketch

Make your CV in your school's format and your NIH biosketch from it, then download both as Word files.